The frontline HCC study evaluating MT-303 (NCT06478693) is a multi-center, open-label, dose-escalation and expansion trial designed to investigate the safety, tolerability, pharmacokinetics, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results